CYP2D6 testing for breast cancer patients: is there more to the story?

Henry NL, Hayes DF, Rae JM. CYP2D6 testing for breast cancer patients: is there more to the story? Oncology (Williston Park). 2009 Dec; 23(14):1236, 1243, 1249.

View in: PubMed

subject areas

Biomarkers
Breast Neoplasms
Chemotherapy, Adjuvant
Cytochrome P-450 CYP2D6
Drug Incompatibility
Female
Humans
Medication Adherence
Polymorphism, Single Nucleotide
Precision Medicine
Selective Estrogen Receptor Modulators
Tamoxifen

authors with profiles

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement